Navigation Links
Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
Date:6/1/2011

AUSTIN, Texas, June 1, 2011 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX), today announced it has signed a global sales and distribution agreement with Life Technologies Corporation (NASDAQ: LIFE) for its award-winning MAGPIX multiplexing instrument for analysis of proteins for research use. Launched in July 2010, MAGPIX is a compact multiplex analyzer that can quickly, accurately and reproducibly detect 50 different analytes simultaneously on a single sample, including proteins and nucleic acids.

"We are very pleased to have Life Technologies as a global distribution partner for MAGPIX. This new, highly innovative instrument is an important advancement in Luminex's goal to create multiplexing solutions for a range of applications and for laboratories of all sizes," said Michael F. Pintek, senior vice president of operations for Luminex. "With its global scope, Life Technologies helps ensure that this advanced multiplexing solution reaches the right scientists and researchers. This partnership will help accelerate science and improve the efficiency of disease-related research around the world."

Providing nearly 5,000 data points in under an hour, MAGPIX was designed to meet the needs of laboratories, academic researchers and scientists who, until now, have not been able to take advantage of the power of multiplexing because of resource and space limitations. Based on Luminex's xMAP® Technology, the easy-to-use MAGPIX instrument is compact - comparable in size to a desktop computer - making it attractive to a broad array of laboratories and institutions. Due to its adaptabil
'/>"/>

SOURCE Luminex Corporation; Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
2. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
3. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
4. Luminex Corporation to Present at UBS Global Life Sciences Conference
5. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
6. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
7. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
8. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
9. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
10. Luminex Corporation Reports Third Quarter 2010 Results
11. Luminex Corporation to Present at Stephens Fall Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Texas , July 30, 2015 /PRNewswire/ ... company focused on gynecologic disease, announced today ... financial results after the market close on ... investor conference call and webcast at 4:30pm ... 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
(Date:7/30/2015)... Flexpoint Ford, a private equity firm focused ... that it has entered into a partnership with ... form Kastle Therapeutics, LLC (Kastle).  The new company, headquartered ... acquiring, developing and commercializing pharmaceuticals targeted toward diseases with ... therapies already approved for marketing, as well as clinical ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... the world,s only amputee professional kiteboarder and waverider, will be ... Thursday, Jan. 6 on the Discovery Channel,s HD Theater. All ... 17th. Using the Renegade prosthetic foot from Freedom ... the wind as it whistles through the most rugged terrain ...
... 2011 BioDrain Medical, Inc. (OTC Bulletin Board: BIOR ... surgical fluid disposal, announced today it is eligible for trading ... The company was admitted to the OTCBB early in 2010 ... market maker going out of business.  For the last several ...
Cached Medicine Technology:Discovery Channel to Feature World's Only Amputee Kiteboarder 2BioDrain Medical, Inc. Is Eligible for Trading on the OTCBB, Notice of Allowance on Canadian Patent Application 2
(Date:7/30/2015)... ... July 30, 2015 , ... World ... am Fine, an app invention that can help people during emergencies. , "The ... Cooper, CEO and Creative Director of World Patent Marketing. "Currently, there are about ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... OSF ... to results from the 2015 Most Wired Survey conducted by Hospitals & Health Networks. ... health system owned and operated by The Sisters of the Third Order of ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... entitled " Lovetraction Lines ." It's for women interested in improving their love ... desire. The course, which officially launched to the public early this morning, has ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... worked to protect victims in San Diego, California’s Gaslamp Quarter Plaza for five ... Gaslamp Quarter Plaza actively monitor the area for any suspicious activity. These cameras ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Google recently ... an upcoming dedicated web site. As discussed in a June 8, 2015 article published ... collisions reported so far have been caused by its computer-driven cars, which such industry ...
Breaking Medicine News(10 mins):Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3
... who bring them pebbles to build egg nests. Hummingbirds ... guarded by larger males. , New research shows ... will still attempt to trade sexual currency for provisions, ... Michigan School of Public Health. , The exchange of ...
... Men with serious injuries, such as traumatic brain injury or ... If these men have strong traditional masculine ideas and abuse ... and come to terms with their emotions and situations. A ... find better ways to understand and treat men who fit ...
... clinical trials could start in several years, study says , , ... inhibits the formation of scar tissue at the site of ... regenerate has been developed by researchers at Northwestern University in ... ability to regrow after a spinal injury, but they,re blocked ...
... extend safety practices, CDC reports , , THURSDAY, April 10 ... of foodborne illnesses have remained constant in the United ... And that leveling off of the rate of food ... Control and Prevention,s goal of reducing the overall number ...
... cancer-killing activities in cultured cells. While they are ... trials, just how they execute their effects is ... papers, Vanderbilt-Ingram Cancer Center investigators provide a potential ... cells and offer clues about possible adverse effects ...
... PHILADELPHIA, April 10 SAGES 2008 ANNUAL ... a new study showing,laparoscopic surgery reduced the ... when compared to open surgery in a ... of the following three surgical,procedures: hysterectomy, cholecystectomy ...
Cached Medicine News:Health News:Just like penguins and other primates, people trade sex for resources 2Health News:Triple threat: Young macho men with serious injuries often abuse alcohol 2Health News:Gel Enables Severed Spinal Cord Fibers to Regrow 2Health News:Foodborne Illnesses Remain Constant in U.S. 2Health News:Foodborne Illnesses Remain Constant in U.S. 3Health News:The good and bad side of anti-cancer compounds 2Health News:The good and bad side of anti-cancer compounds 3Health News:Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery 2Health News:Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery 3
... Bard Collagen Implant, the world's leading bulking ... for the treatment of Stress Urinary Incontinence ... surrounding urethral tissue to aid coaptation in ... body's own structure, Contigen Bard Collagen Implant ...
... Titan™ Inflatable Penile Prosthesis (IPP) ... to be surgically implanted into ... of erectile dysfunction (also known ... the patient with voluntary control ...
... The AMS 650™ and 600M™ malleable ... many patientsespecially those with limited dexterity. These ... allows the patient to position them in ... make the penis rigid enough for sexual ...
... continues to be a proven, reliable penile ... to have mechanical reliability rates of over ... ioflex material contributes to excellent mechanical reliability ... Bioflex: ,Provides maximum, controlled girth expansion to ...
Medicine Products: